vTv Therapeutics Files 2024 Proxy Statement
Ticker: VTVT · Form: DEF 14A · Filed: Apr 25, 2025 · CIK: 1641489
| Field | Detail |
|---|---|
| Company | Vtv Therapeutics Inc. (VTVT) |
| Form Type | DEF 14A |
| Filed Date | Apr 25, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: proxy-statement, executive-compensation, corporate-governance
TL;DR
vTv Therapeutics DEF 14A out: Proxy details exec pay for 2024, names Sekhri, Nelson, Prasad.
AI Summary
vTv Therapeutics Inc. filed a DEF 14A on April 25, 2025, for the fiscal year ending December 31, 2024. The filing details executive compensation and related party transactions. Key individuals mentioned in relation to compensation include Sekhri, Nelson, and Prasad, with compensation data presented for the fiscal years 2022, 2023, and 2024.
Why It Matters
This filing provides crucial information for shareholders regarding executive compensation and corporate governance decisions made by vTv Therapeutics Inc. during the 2024 fiscal year.
Risk Assessment
Risk Level: medium — DEF 14A filings often contain information about executive compensation, potential conflicts of interest, and shareholder proposals, which can impact investor sentiment and stock price.
Key Numbers
- 2024 — Fiscal Year End (The most recent fiscal year for which compensation data is detailed in the filing.)
- 2023 — Fiscal Year (Previous fiscal year for which compensation data is provided.)
- 2022 — Fiscal Year (Earlier fiscal year for which compensation data is provided.)
Key Players & Entities
- vTv Therapeutics Inc. (company) — Filer of the DEF 14A
- Sekhri (person) — Executive/Director mentioned in compensation tables
- Nelson (person) — Executive/Director mentioned in compensation tables
- Prasad (person) — Executive/Director mentioned in compensation tables
- 20250425 (date) — Filing date of the DEF 14A
- 2024-12-31 (date) — Fiscal year end for which the filing provides data
FAQ
What is the primary purpose of this DEF 14A filing by vTv Therapeutics Inc.?
The primary purpose of this DEF 14A filing is to provide information to shareholders regarding the company's annual meeting, including details on executive compensation, director nominations, and other corporate governance matters for the fiscal year ending December 31, 2024.
Who are the key individuals whose compensation is detailed in the filing?
The filing details compensation for key individuals such as Sekhri, Nelson, and Prasad, with data presented for the fiscal years 2022, 2023, and 2024.
When was this DEF 14A filing submitted to the SEC?
This DEF 14A filing was submitted to the SEC on April 25, 2025.
What is the company's fiscal year end?
vTv Therapeutics Inc.'s fiscal year ends on December 31st.
What is the SIC code for vTv Therapeutics Inc.?
The Standard Industrial Classification (SIC) code for vTv Therapeutics Inc. is 2834, which corresponds to Pharmaceutical Preparations.
Filing Details
This Form DEF 14A (Form DEF 14A) was filed with the SEC on April 25, 2025 by Sekhri regarding vTv Therapeutics Inc. (VTVT).